Pliant Therapeutics is focused on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.
Milestones
- 2015 → Founded
- 2018 → Partnered, Series B
- 2020 → IPO; NASDAQ: PLRX
Pliant Therapeutics is focused on discovering, developing, and commercializing breakthrough treatments for fibrotic diseases.